• Home
  • About
    • Management Team
  • Products
    • PLUS Human Platelet Lysate
    • BioBandage
  • Services
    • Resources Available
  • Newsroom
    • Compass Blog
  • Careers
  • Online Order Form
  • Contact Us
    • Distributors
  • Customer Referral
Compass Biomedical
  • Home
  • About
    • Management Team
  • Products
    • PLUS Human Platelet Lysate
    • BioBandage
  • Services
    • Resources Available
  • Newsroom
    • Compass Blog
  • Careers
  • Online Order Form
  • Contact Us
    • Distributors
  • Customer Referral

From the Newsroom


Blog Posts

June 28, 2017 - Clinical Grade vs GMP Grade Terminology for Ancillary Materials

March 1, 2017 - Generation of Monocyte Derived Dendritic Cells Using Xeno-free GMP Grade Human Platelet Lysate

Press Releases

December 12, 2016 - Arteriocyte, Inc. Announces Name Change to Compass Biomedical

October 25, 2016 -  Arteriocyte Presents its Update on Development of Bioactive Coating to Maintain Tissue Viability in Acute Battlefield Injuries for the ACCSIL Bandage Program

October 6, 2015 – Compass Biomedical Announces FDA Drug Master File Acceptance for PLUS Human Platelet Lysate

May 2, 2014 – Arteriocyte awarded FDA IDE approval to initiate clinical eveluation of MAGELLAN® Bio-Bandage in Acute Deep Partial Thickness Thermal Injuries

June 3, 2013 – Arteriocyte announces Launch of Compass Biomedical

July 20, 2011 – Arteriocyte receives $1 Million award from Ohio Third Frontier Program to advance its NANEX technology toward clinical use

December 2, 2010 – Launch of NANEX Stem Cell Expansion System at the upcoming American Society of Cell Biology Meeting

Meetings & Events

ISCT Regional Meeting 2019 - International Society for Cellular Therapy
Madison, Wisconsin
September 13 - 15,  2019
Booth # 306

Grants and Awards

​Compass Biomedical is proud to announce that it has awarded its first Conference Participation Grant in 2017. The award is intended to cover the conference registration fees for academic researchers working on interesting human platelet lysate (hPL) projects.  The grant allows the awardee to present their research at a relevant conference.
 
Cátia Bandeiras from the Institute of Data, Systems and Society at MIT was chosen to present her work at the Cell and Gene Therapy Bioprocessing and Commercialization conference held in Boston, MA September 26th through the 28th.
 
She will be presenting her poster titled “Cost effectiveness analysis of expansion of bone marrow mesenchymal stem cells (BM-MSCs) and adipose stem cells (ASCs) with PLUS™ human platelet lysate (hPL).”
 
If you are interested in presenting your work at a conference in 2018 and would like to be considered for the Compass Biomedical Conference Participation Grant, please contact us at research@compassbiomed.com.


​45 South Street Hopkinton, MA 01748, USA
Email: info@compassbiomed.com
Phone: 855-475-7587
Picture

Copyright© 2017 Compass Biomedical, Inc. All rights reserved.
  • Home
  • About
    • Management Team
  • Products
    • PLUS Human Platelet Lysate
    • BioBandage
  • Services
    • Resources Available
  • Newsroom
    • Compass Blog
  • Careers
  • Online Order Form
  • Contact Us
    • Distributors
  • Customer Referral